UBS (UBS)
(Delayed Data from NYSE)
$28.03 USD
-1.13 (-3.88%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $28.03 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value D Growth A Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$28.03 USD
-1.13 (-3.88%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $28.03 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value D Growth A Momentum B VGM
Zacks News
Is Vanguard Wellington Investor (VWELX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for VWELX
Is T. Rowe Price QM US Small Cap Growth Equity (PRDSX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for PRDSX
Is Matthews China Fund (MCHFX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for MCHFX
Is Kinetics Small Cap Opportunity No Load (KSCOX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for KSCOX
Mitsubishi UFJ (MUFG) Records Dismal Earnings in Nine Months
by Zacks Equity Research
Mitsubishi UFJ (MUFG) reports disappointing earnings for the first nine months of fiscal 2019 (Dec 31, 2019), mainly affected by net extraordinary losses which resulted from one-time amortization of goodwill.
UBS Group Unit Under Investigation By Italy's Prosecutors
by Zacks Equity Research
UBS Group (UBS) is accused of hiding suspicious operations and obstructing work of the regulators.
UBS vs. WBK: Which Stock Is the Better Value Option?
by Zacks Equity Research
UBS vs. WBK: Which Stock Is the Better Value Option?
Deutsche Bank (DB) Posts Q4 Loss on Low Revenues, High Costs
by Zacks Equity Research
Deutsche Bank's (DB) Q4 results reflect the adverse impact of overhaul costs and decline in revenues.
Should Value Investors Buy UBS (UBS) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
JPMorgan (JPM) Mulls to Cut 1% Jobs in Consumer Division
by Zacks Equity Research
JPMorgan (JPM) is considering job cuts in its consumer unit, as technological advancements will require less workforce and also reduce costs.
ICICI Bank (IBN) Q3 Earnings Increase Y/Y, Expenses Rise
by Zacks Equity Research
ICICI Bank (IBN) witnesses rise in revenues and higher expenses in third-quarter fiscal 2020 (ended Dec 31).
UBS Group's (UBS) Q4 Earnings Rise Y/Y on Lower Expenses
by Zacks Equity Research
UBS Group (UBS) fourth-quarter results benefit from higher interest income and fall in expenses.
The Zacks Analyst Blog Highlights: Beyond Meat, UBS, Walmart, Restaurant Brands International and Conagra Brands
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Beyond Meat, UBS, Walmart, Restaurant Brands International and Conagra Brands
UBS or WBK: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
UBS vs. WBK: Which Stock Is the Better Value Option?
Goldman Sachs (GS) on Hiring Spree, to Add 600 Jobs in China
by Zacks Equity Research
In sync with Goldman Sachs' (GS) efforts to gain majority control in the joint venture and improve profitability, the bank announces plans to increase workforce in China.
The Zacks Analyst Blog Highlights: Novartis, McDonald's, Bristol-Myers Squibb, CME and UBS
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Novartis, McDonald's, Bristol-Myers Squibb, CME and UBS
Top Analyst Reports for Novartis, McDonald's & Bristol-Myers Squibb
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Novartis (NVS), McDonald's (MCD) and Bristol-Myers Squibb (BMY).
UBS' Wealth Management Overhaul to Result in 500 Job Cuts
by Zacks Equity Research
UBS Group (UBS) to cut jobs in the private banking business in order to reduce costs and restructure businesses.
China Regulator Lifts Ownership Limits for Foreign Companies
by Zacks Equity Research
Foreign firms are expected to benefit from China's move to lift ownership limits within its financial sector.
UBS Group Rides on Cost Control Efforts: Should You Hold?
by Zacks Equity Research
UBS Group (UBS) is focused on achieving its performance targets through execution of cost management and several restructuring initiatives.
The Zacks Analyst Blog Highlights: Procter & Gamble, Enterprise Products, UBS, Cintas and OGE
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Procter & Gamble, Enterprise Products, UBS, Cintas and OGE
Top Analyst Reports for Procter & Gamble, Enterprise Products & UBS Group
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including The Procter & Gamble Company (PG), Enterprise Products Partners L.P. (EPD) and UBS Group AG (UBS).
Credit Suisse Fined $6.5M by FINRA for Supervisory Failure
by Zacks Equity Research
FINRA and major exchanges fine Credit Suisse (CS) with $6.5 million for supervisory lapses.
Mitsubishi UFJ's Acquisitions Aid Growth Amid Rising Costs
by Zacks Equity Research
Mitsubishi UFJ (MUFG) displays growth through acquisitions and remains focused on its business-upgradation plan, though rising expenses and Bank of Japan's negative interest-rate policy are concerns.
BlackRock (BLK) to Expand in China With Majority Owned JV
by Zacks Equity Research
BlackRock's (BLK) efforts to expand in China will help diversification, and lead to further top-line growth.